“Clinical and Metabolic Determinants of Hepatic Fibrosis in Patients with Metabolic Dysfunction- Associated Steatotic Liver Disease (MASLD) – Insights from a Bangladeshi Cohort” (2025) The Insight, 8(03), pp. 588–592. doi:10.5281/zenodo.18014065.